Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer

NCT00777101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer
Breast Cancer

Interventions

DRUG: Neratinib
DRUG: Lapatinib
DRUG: Capecitabine

Sponsor

Puma Biotechnology, Inc.